MRD-negative complete remission in relapsed refractory hairy cell leukemia with bendamustine and obinutuzumab

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1-2
Number of pages2
JournalAnnals of Hematology
DOIs
StateAccepted/In press - Dec 28 2017

ASJC Scopus subject areas

  • Hematology

Cite this